Comparative microsomal oxidation of febantel and its metabolite fenbendazole in various animal species.

This research paper primarily examines how febantel and one of its active metabolites, fenbendazole, are metabolized by several animal species. The scientists find that the rate of this metabolic process varies between species, and this could potentially have significant toxicological implications.

Overview of the Research

• The study focuses on the in vitro metabolism (chemical transformations that a compound undergoes inside an organism) of febantel (FBT) and its pharmacologically active metabolite fenbendazole (FBZ).
• The researchers used liver microsomal preparations from various animal species, including sheep, calf, horse, pig, rat, chicken, and trout.

Metabolic Findings

• They found that the oxidation of FBT to the corresponding sulphoxide occurs at a much faster rate compared to a similar reaction with FBZ in all the tested species, except trout.
• Interestingly, FBT was also metabolized further through a process called cyclization and additional oxidation steps in several species.

Toxicological Considerations

• These metabolic observations are important from a toxicological point of view. This importance arises because the metabolite oxfendazole, which is created in the process, has been found to have higher teratogenic effects.
• Teratogenic effects refer to the capability of a compound to cause birth defects or developmental malformations.

Variability Among Species

• The research observed that reaction rates varied over different species; pigs and sheep displayed the most rapid rates of reaction.
• This suggests that the metabolism of febantel and fenbendazole might be species-dependent, which could influence the efficacy, safety and recommended dosage of these compounds in different species.